PURPOSE: The purpose of the research is to study the effect of acute inhibition of intravascular lipolysis on myocardial substrate selection during hypertriglyceridemia using in vivo radiotracer analysis and positron emission tomography. PROCEDURES: We induced acute hypertriglyceridemia in vivo using an intravenous infusion of Intralipid 20% (IL) without and with acute inhibition of fatty acid delivery from circulating triglycerides with injection of Triton WR-1339 (TRI) during a euglycemic-hyperinsulinemic clamp in Wistar rats. We determined the effect of TRI on myocardial uptake of circulating triglycerides and free fatty acids using intravenous injection of [(3)H]-triolein and [(14)C]-bromopalmitate, respectively. Myocardial blood flow, oxidative metabolism, and metabolic rate of glucose (MMRG) were determined using micro-positron emission tomography (microPET) with [(13)N]-ammonia, [(11)C]-acetate, and 2-deoxy-2-[F-18]fluoro-D: -glucose (FDG). RESULTS: TRI reduced myocardial incorporation of [(3)H]-triolein but not [(14)C]-bromopalmitate showing that it selectively reduces myocardial fatty acid delivery from circulating triglycerides but not from free fatty acids. IL reduced myocardial blood flow and MMRG by 37% and 56%, respectively, but did not affect myocardial oxidative metabolism. TRI did not abolish the effect of IL on myocardial blood flow and MMRG. CONCLUSIONS: Hypertriglyceridemia acutely reduces myocardial blood flow and MMRG in rats, but this effect is not explained by increased myocardial fatty acid delivery through intravascular triglyceride lipolysis.
PURPOSE: The purpose of the research is to study the effect of acute inhibition of intravascular lipolysis on myocardial substrate selection during hypertriglyceridemia using in vivo radiotracer analysis and positron emission tomography. PROCEDURES: We induced acute hypertriglyceridemia in vivo using an intravenous infusion of Intralipid 20% (IL) without and with acute inhibition of fatty acid delivery from circulating triglycerides with injection of Triton WR-1339 (TRI) during a euglycemic-hyperinsulinemic clamp in Wistar rats. We determined the effect of TRI on myocardial uptake of circulating triglycerides and free fatty acids using intravenous injection of [(3)H]-triolein and [(14)C]-bromopalmitate, respectively. Myocardial blood flow, oxidative metabolism, and metabolic rate of glucose (MMRG) were determined using micro-positron emission tomography (microPET) with [(13)N]-ammonia, [(11)C]-acetate, and 2-deoxy-2-[F-18]fluoro-D: -glucose (FDG). RESULTS:TRI reduced myocardial incorporation of [(3)H]-triolein but not [(14)C]-bromopalmitate showing that it selectively reduces myocardial fatty acid delivery from circulating triglycerides but not from free fatty acids. IL reduced myocardial blood flow and MMRG by 37% and 56%, respectively, but did not affect myocardial oxidative metabolism. TRI did not abolish the effect of IL on myocardial blood flow and MMRG. CONCLUSIONS:Hypertriglyceridemia acutely reduces myocardial blood flow and MMRG in rats, but this effect is not explained by increased myocardial fatty acid delivery through intravascular triglyceride lipolysis.
Authors: Etienne Croteau; François Bénard; M'hamed Bentourkia; Jacques Rousseau; Michel Paquette; Roger Lecomte Journal: J Nucl Med Date: 2004-11 Impact factor: 10.057
Authors: Xiuli Ci; Frédérique Frisch; François Lavoie; Pascale Germain; Roger Lecomte; Johan E van Lier; François Bénard; André C Carpentier Journal: Mol Imaging Biol Date: 2006 Jul-Aug Impact factor: 3.488
Authors: N Sambandam; M A Abrahani; E St Pierre; O Al-Atar; M C Cam; B Rodrigues Journal: Arterioscler Thromb Vasc Biol Date: 1999-06 Impact factor: 8.311
Authors: Teemu O Takala; Pirjo Nuutila; Kari Pulkki; Vesa Oikonen; Tove Grönroos; Timo Savunen; Tommi Vähäsilta; Matti Luotolahti; Markku Kallajoki; Jörgen Bergman; Sarita Forsback; Juhani Knuuti Journal: Eur J Nucl Med Mol Imaging Date: 2002-10-03 Impact factor: 9.236
Authors: P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius Journal: J Clin Invest Date: 1992-06 Impact factor: 14.808
Authors: Sébastien M Labbé; Etienne Croteau; Thomas Grenier-Larouche; Frédérique Frisch; René Ouellet; Réjean Langlois; Brigitte Guérin; Eric E Turcotte; André C Carpentier Journal: Diabetes Date: 2011-01-12 Impact factor: 9.461
Authors: Michael C Kreissl; David B Stout; Koon-Pong Wong; Hsiao-Ming Wu; Evren Caglayan; Waldemar Ladno; Xiaoli Zhang; John O Prior; Christoph Reiners; Sung-Cheng Huang; Heinrich R Schelbert Journal: EJNMMI Res Date: 2011-07-06 Impact factor: 3.138
Authors: Sébastien M Labbé; Thomas Grenier-Larouche; Christophe Noll; Serge Phoenix; Brigitte Guérin; Eric E Turcotte; André C Carpentier Journal: Diabetes Date: 2012-11 Impact factor: 9.461
Authors: Elise Roussel; Marie-Claude Drolet; Elisabeth Walsh-Wilkinson; Wahiba Dhahri; Dominic Lachance; Suzanne Gascon; Otman Sarrhini; Jacques A Rousseau; Roger Lecomte; Jacques Couet; Marie Arsenault Journal: Biomed Res Int Date: 2015-10-25 Impact factor: 3.411